COLLEGIUM PHARMACEUTICAL, INC

By person

16 insiders · 0 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Rubric Capital Management LP entity

10% owner

—

3,132,743

$106.67M

−0.8%

Karnani Vikram

President and CEO

—

197,864

$6.74M

+52,523%

Tupper Colleen

EVP & Chief Financial Officer

—

147,282

$5.01M

+12.6%

SANTINI GINO

Director

—

112,483

$3.83M

+48.7%

Kuhlmann Shirley R.

EVP and General Counsel

—

108,137

$3.68M

−9.3%

Freund John Gordon

Director

—

107,081

$3.65M

+22.7%

Smith Thomas B

EVP and Chief Medical Officer

—

90,651

$3.09M

+63.8%

Dieter David

EVP & General Counsel

—

77,071

$2.62M

+733.7%

Dreyer Scott

EVP & Chief Commercial Officer

—

71,770

$2.44M

−32.2%

BOHLIN GAREN G

Director

—

71,000

$2.42M

+35.3%

Fallon John A.

Director

—

64,634

$2.20M

+17.9%

Balice-Gordon Rita J.

Director

—

61,370

$2.09M

+32.0%

Heffernan Michael Thomas

Director

—

50,328

$1.71M

+10.6%

Paya Carlos V

Director

—

28,323

$964.40K

—

Lurker Nancy

Director

—

26,758

$911.11K

—

Glancy Donovan Michael

Director

—

17,482

$595.26K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

COLLEGIUM PHARMACEUTICAL, INC

By person

Individual transactions

What was left out